ICD-10: | Z79.02 |
---|---|
Short Description: | Long term (current) use of antithrombotics/antiplatelets |
Long Description: | Long term (current) use of antithrombotics/antiplatelets |
· For long term use of Plavix the most appropriate code to assign would be Z79.02. Plavix (Clopidogrel Bisulfate) is an antiplatelet agent. Look it up by going to the Alpha index -Long term drug therapy, antiplatelet Z79.02. Furthermore, if you go to Appendix D of your ICD-10-CM book you will also find that Plavix and Clopidogrel Bisulfate are both listed under Z79.02.
· Z79.02 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z79.02 became effective on October 1, 2021. This is the American ICD-10-CM version of Z79.02 - other international versions of ICD-10 Z79.02 may differ.
ICD-10-CM Diagnosis Code Z79.0. Long term (current) use of anticoagulants and antithrombotics/antiplatelets. Long term (current) use of antocoag/antithrom/angiplate; long term (current) use of aspirin (Z79.82) ICD-10-CM Diagnosis Code Z79.0. Long term (current) use of anticoagulants and antithrombotics/antiplatelets.
500 results found. Showing 26-50: ICD-10-CM Diagnosis Code O24.9. Unspecified diabetes mellitus in pregnancy, childbirth and the puerperium. Unsp diabetes in pregnancy, childbirth and the puerperium; code for long-term (current) use of …
Long term (current) use of antithrombotics/antiplatelets The 2022 edition of ICD-10-CM Z79. 02 became effective on October 1, 2021. This is the American ICD-10-CM version of Z79.
Z79. 82 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
ICD-10 Code for Other long term (current) drug therapy- Z79. 899- Codify by AAPC.
ICD-10-CM Code for Long term (current) use of anticoagulants Z79. 01.
The ICD-10 section that covers long-term drug therapy is Z79, with many subsections and specific diagnosis codes.
Z79. 01 – long-term (current) use of anticoagulants.
ICD-10-CM Diagnosis Code Z79 Z79.
ICD-10 | Other fatigue (R53. 83)
Other long term (current) drug therapy The 2022 edition of ICD-10-CM Z79. 899 became effective on October 1, 2021. This is the American ICD-10-CM version of Z79.
Plavix (clopidogrel bisulfate) and Coumadin (warfarin) are anticoagulants (blood thinners) used to treat patients with acute coronary syndrome, heart attack (myocardial infarction), peripheral vascular disease, and ischemic strokes.
2022 ICD-10-CM Diagnosis Code Z51. 81: Encounter for therapeutic drug level monitoring.
Current guidelines suggest that anticoagulants be continued indefinitely in unprovoked VTE patients with nonhigh bleeding risk. If a patient has a yearly bleeding risk on anticoagulants > 3% (ie, high bleeding risk), we would expect a 20-year cumulative risk for major bleed of ∼60%.
The 2022 edition of ICD-10-CM Z79.02 became effective on October 1, 2021.
Z77-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status
Chronic embolism and thrombosis of deep veins of low extrm; personal history of venous embolism and thrombosis (Z86.718); code, if applicable, for associated long-term (current) use of anticoagulants (Z79.01)
Unsp diabetes in pregnancy, childbirth and the puerperium; code for long-term (current) use of insulin (Z79.4)
The 2022 edition of ICD-10-CM Z79.01 became effective on October 1, 2021.
Z77-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status
Since the inception of ICD-10-CM there has been confusion as to whether or not D68.32, Hemorrhagic disorder due to extrinsic circulating anticoagulants should be reported when a patient has bleeding due to anticoagulant use such as Coumadin. In ICD-9-CM coding, the bleeding site was coded followed by the adverse effect of Coumadin external cause code. In ICD-10-CM a new code was developed, D68.32.
AHA has recently published the 2017 AHA ICD-10 Coding Handbook and this problem seems to have been corrected. HIA had written a letter to AHA regarding this, and has not yet received and answer, however the answer seems to be confirmed in the corrected 2017 AHA ICD-10 Coding Handbook in Chapter 17.
Z79.02 is a billable diagnosis code used to specify a medical diagnosis of long term (current) use of antithrombotics/antiplatelets. The code Z79.02 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.#N#The ICD-10-CM code Z79.02 might also be used to specify conditions or terms like long-term current use of antiplatelet drug or long-term current use of antithrombotic. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.#N#The code Z79.02 describes a circumstance which influences the patient's health status but not a current illness or injury. The code is unacceptable as a principal diagnosis.
Congenital heart defects. There are two main types of blood thinners. Anticoagulants such as heparin or warfarin (also called Coumadin) slow down your body's process of making clots. Antiplatelet drugs, such as aspirin, prevent blood cells called platelets from clumping together to form a clot.
Z79.02 is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.